The treatment of prostate cancer is rapidly changing, and a new consensus for management is required. In this article, Oliver and Neal consider data from studies of hormone therapy, surgery, radiotherapy and active surveillance, and they discuss which options might be suitable in which patients.
- R Tim D Oliver
- David E Neal
